Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab175520-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,668.90 | |
Ab175520-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $4,668.90 |
Product Name | efgartigimod alfa |
---|---|
Synonyms | ARGX-113;efgartigimod alfa-fcab;Vyvgart |
Specifications & Purity | Moligand™ |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antibody of Fc fragment of IgG receptor and transporter |
CAS | Ab175520 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IMGT/mAb-DB | 731 |
---|
Enter Lot Number to search for COA:
1. Liu L, Garcia AM, Santoro H, Zhang Y, McDonnell K, Dumont J, Bitonti A. (2007) Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade.. J Immunol, 178 (8): (5390-8). [PMID:17404325] |
2. Petkova SB, Akilesh S, Sproule TJ, Christianson GJ, Al Khabbaz H, Brown AC, Presta LG, Meng YG, Roopenian DC. (2006) Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.. Int Immunol, 18 (12): (1759-69). [PMID:17077181] |
3. Vaccaro C, Zhou J, Ober RJ, Ward ES. (2005) Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels.. Nat Biotechnol, 23 (10): (1283-8). [PMID:16186811] |
4. Roopenian DC, Akilesh S. (2007) FcRn: the neonatal Fc receptor comes of age.. Nat Rev Immunol, 7 (9): (715-25). [PMID:17703228] |